LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
105,860,530
Share change
+9,079,128
Total reported value
$1,136,914,006
Put/Call ratio
8.2%
Price per share
$10.74
Number of holders
99
Value change
+$98,139,625
Number of buys
65
Number of sells
31

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2015

As of 30 Sep 2015, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 105,860,530 shares. The largest 10 holders included Artal Group S.A., FMR LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, Ulys, L.L.C., VANGUARD GROUP INC, STATE STREET CORP, BlackRock Fund Advisors, BRIDGER MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., and Voya Investment Management LLC. This page lists 99 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.